Search
Close Search

Cxbladder is an Accurate
Genomic Urine Test for 
Bladder Cancer Surveillance

Cxbladder is a non-invasive genomic urine test
that quickly and accurately detects or rules out
bladder cancer in patients monitoring for recurrence.

Contact Us To Learn More
  • Clinically proven: Proven performance in 12 peer-reviewed publications for detection and surveillance. Cxbladder is accessible to 70% of the New Zealand population via public healthcare, and trusted by over 2,000 US urologists in more than 80,000 patients.
  • Non-invasive and easy-to-use: Cxbladder’s unique urine sample collection system is discrete, non-invasive, and easy-to-use, taking only minutes.
  • In-home sampling: To streamline patient care we are now offering an in-home sampling service for comfort and convenience. 
  • Quick: Upon receiving a urine sample, our certified New Zealand laboratory will provide actionable results in 5 days.

Bladder Cancer Patients have Unique Monitoring Needs

Those that have already been treated for bladder cancer have unique monitoring needs to protect against the threat of recurrence. 

Depending on your risk profile, doctors generally recommend a cystoscopy to examine the inside of the bladder and urethra every 3 to 12 months for several years after bladder cancer treatment.

If several years of surveillance have gone by and no cancer recurrence has been detected, a cystoscopy once a year may be enough, though the final decision rests with the physician and additional testing may be required depending on the nature and severity of the original cancer. 

If You’re Being Monitored for Bladder Cancer Recurrence, Ask Your Doctor About Cxbladder 

Cxbladder is a cutting-edge genomic urine test that quickly and accurately detects or rules out bladder cancer. The test combines clinical risk factor markers with genetic information, measuring five biomarker genes to detect the presence or absence of bladder cancer.

Cxbladder Monitor is reliable non-invasive surveillance alternative designed to rule out the return of bladder cancer. The test provides accurate results with a single urine sample, reducing the need for frequent cystoscopies which can be both uncomfortable and inconvenient.

Download our Patient Brochure     Contact us to learn more 

Proven Performance

With proven performance in more than 20 peer-reviewed publications for bladder cancer detection and surveillance, Cxbladder is accessible to 70% of the New Zealand population via public healthcare. In the US, Cxbladder is trusted by over 2,000 urologists in more than 80,000 patients.

Browse our Clinical Publications

Non-Invasive and Easy-to-Use

Cxbladder’s unique urine sample collection system is discrete, non-invasive, and easy-to-use, taking only minutes. Watch our instructions for use video to learn more.

In-Home Sampling for Comfort and Convenience

To simplify and streamline the bladder cancer testing process, we are now offering in-home sampling for patients around the country. Patients have the option of submitting their Cxbladder urine sample in the comfort of their own home without the need to physically visit a clinic.

If you’re a patient monitoring for bladder cancer recurrence, or worried about blood in urine, or any other symptom of bladder cancer, we recommend you speak to your doctor and check if Cxbladder in-home sampling is right for you and publicly funded in your region. In regions where Cxbladder home testing is not yet provided via public healthcare, our tests are available to buy online.

Learn More About our Sampling Process

The Difference in Cancer Detection

Cxbladder is an accurate and non-invasive surveillance alternative designed to rule out the return of bladder cancer. The test provides reliable results with a single urine sample, reducing the need for frequent cystoscopies which can be both uncomfortable and inconvenient. 

Call us - NZ: 0800-CXBLADR (0800-2925-237)

Contact us to learn more

Last Updated: 16 Aug 2021 05:04 pm